It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...

More than 20 years after gaining FDA approval for Flovent, GSK still controlled the market in the U.S. for the asthma inhaler through a partnership with an “authorized generic” dealer, a setup that ...

The White House’s direct-to-consumer (DTC) platform, TrumpRx, is steadily expanding its catalogue, with products from GSK and Amgen the latest to join the collection of drugs offered through the ...

Asthma + Lung said two thirds of people with asthma were not receiving adequate levels of care An asthma charity has called for better monitoring of the use of inhalers after the death of a ...

The Trump administration has expanded its TrumpRx drug pricing platform to 54 medications, adding 11 drugs since its February launch, as questions persist about the site’s overall impact on ...

Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused disruptions for physicians and health consequences for families nationwide, ...

GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...

The US federal government has named the next 15 medicines that will be subject to Medicare pricing negotiation and reductions due to come into effect at the start of 2028. The list has been announced ...

She cited one patient whose parents, after the insurer refused to cover an alternative inhaler due to the cost, had to cut the 5-year-old’s dosage in half. The child ended up needing emergency oxygen ...

Premiums have more than doubled for millions of Americans since enhanced Affordable Care Act tax credits expired, and millions more are projected to lose coverage over the next decade. The ...